Gracell Biotechnologies Inc. Sponsored ADR Current Ratio 2022-2023 | GRCL
Gracell Biotechnologies Inc. Sponsored ADR current ratio from 2022 to 2023. Current ratio can be defined as a liquidity ratio that measures a company's ability to pay short-term obligations.
| Current Ratio Historical Data | |||
|---|---|---|---|
| Date | Current Assets | Current Liabilities | Current Ratio |
| 2023-09-30 | $0.24B | $0.03B | 7.73 |
| 2023-06-30 | $0.17B | $0.03B | 6.44 |
| 2023-03-31 | $0.19B | $0.03B | 6.26 |
| 2022-12-31 | $0.22B | $0.03B | 6.78 |
| 2022-09-30 | $0.24B | $0.04B | 6.77 |
| 2022-06-30 | $0.26B | $0.03B | 8.01 |
| 2022-03-31 | $0.28B | $0.03B | 9.41 |
| 2021-12-31 | $0.30B | $0.02B | 12.15 |
| 2021-09-30 | $0.31B | $0.02B | 14.70 |
| 2021-06-30 | $0.33B | $0.02B | 16.05 |
| 2021-03-31 | $0.34B | $0.02B | 18.38 |
